This troche formulation is a compounded blend of estriol, estradiol, and estrone, presented in an 80%-10%-10% ratio. The dosage range for this medication is between 0.625-2.5 mg. The unique combination of these hormones makes this formulation an effective treatment for a variety of conditions, including menopausal symptoms, postmenopausal osteoporosis, and hormone replacement therapy.

Estriol, which constitutes 80% of the formulation, is a weak estrogen that is known to alleviate symptoms such as hot flashes and night sweats. Estradiol, making up 10% of the formulation, is a stronger estrogen that aids in reducing vaginal dryness and improving bone density. The remaining 10% is estrone, a weaker estrogen that helps to reduce the risk of endometrial hyperplasia.

The troche is a square-shaped solid dosage form designed to dissolve slowly in the mouth. The medication is delivered through absorption by the oral mucosa, allowing for targeted local or systemic effects. This method of delivery ensures a steady release of the hormones into the body, providing relief from symptoms over a sustained period.

It is crucial to note that this formulation should not be used by women who are pregnant or breastfeeding. As with any medication, it is important to discuss potential risks and benefits with your healthcare provider before starting this treatment. Regular monitoring and dosage adjustments may be necessary to ensure the medication is working effectively and safely.

If you have any questions about this troche formulation or how it can help manage your condition, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is equipped with the knowledge and expertise to assist you in understanding your medication and its effects.

This compounded formulation of Estriol/Estradiol/Estrone [80%-10%-10%] 0.625-2.5 mg Troche is a specialized medication used to manage a variety of conditions. It is particularly effective in treating menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. The Estriol component, a weak estrogen, is primarily responsible for alleviating these symptoms.

The Estradiol and Estrone components, stronger and weaker estrogens respectively, contribute to the reduction of osteoporosis risk. These components also aid in managing menopausal symptoms. Furthermore, this formulation is utilized in hormone replacement therapy, a treatment approach used to supplement hormones that the body is no longer producing.

It is crucial to be aware that this formulation may interact with other medications. These include anticoagulants, anticonvulsants, and certain antibiotics. Additionally, this formulation may increase the risk of certain side effects, such as nausea, vomiting, and headaches. More serious risks include an increased likelihood of developing conditions such as breast cancer, stroke, and blood clots.

Given these potential interactions and side effects, it is essential to have a comprehensive discussion with your healthcare provider before starting this medication. This will ensure that the benefits of the medication outweigh any potential risks. If you have any questions or concerns, do not hesitate to reach out to your healthcare provider for further information and guidance.

This troche formulation is a compounded blend of estriol, estradiol, and estrone, in a ratio of 80%-10%-10%, available in doses ranging from 0.625 to 2.5 mg. It is primarily used in the treatment of menopausal symptoms, postmenopausal osteoporosis, and as part of hormone replacement therapy. The estriol component, a mild estrogen, aids in alleviating symptoms such as hot flashes, night sweats, and vaginal dryness. Estradiol, a more potent estrogen, contributes to the reduction of osteoporosis risk and also helps in managing hot flashes and night sweats. Estrone, another form of estrogen, albeit weaker, also assists in reducing osteoporosis risk and managing menopausal symptoms.

The troche is designed to be taken orally, typically once a day, and it is recommended to take it at the same time each day to maintain consistent hormone levels in the body. To minimize the risk of stomach upset, it is advisable to take the troche with food. The troche should be stored at room temperature, away from moisture and heat, to maintain its efficacy.

Before starting this medication, it is crucial to discuss potential side effects with your healthcare provider. Common side effects may include nausea, vomiting, headache, breast tenderness, and vaginal bleeding. It is also important to discuss any potential drug interactions with your healthcare provider before starting this medication.

If you have any questions about this troche formulation or its mechanism of action, please do not hesitate to reach out. Our team of compounding pharmacists at Bayview Pharmacy is here to assist you.

This compounded formulation of Estriol/Estradiol/Estrone [80%-10%-10%] 0.625-2.5 mg Troche is a square-shaped solid dosage form designed to dissolve slowly in the mouth. The medication is delivered through oral mucosa absorption for targeted local or systemic effects. It is used to treat a variety of conditions including hypoestrogenism, endometriosis, premenstrual syndrome, and postmenopausal bleeding. It may also be used to reduce the risk of developing breast cancer in women who are at high risk for the disease.

Additionally, this formulation may be used to treat symptoms of prostate cancer in men, such as hot flashes, night sweats, and decreased libido. It may also be used to treat symptoms of benign prostatic hyperplasia (BPH) in men, such as difficulty urinating, frequent urination, and weak urine stream. This formulation may also be used to treat symptoms of androgen deficiency in men, such as decreased libido, fatigue, and depression.

It is important to note that this formulation should not be used to treat any condition in children or adolescents. Additionally, this formulation should not be used to treat any condition in pregnant or breastfeeding women. If you have any questions about the uses of this formulation, please reach out to us.